Kenneth Cowan, M.D., Ph.D.
Using gene therapy to develop non-toxic cancer treatments

Director, Eppley Cancer Center
Eppley Institute for Cancer Research

Kenneth Cowan, M.D., Ph.D.

Dr. Kenneth Cowan is leading the Eppley Cancer Center to the next level in treatment/research. A world leader in cancer gene therapy, his pioneering work transferring drug-resistant genes into bone marrow cells before transplant demonstrated the feasibility of incorporating new genes into patients. There is hope that this will lead to the development of non-toxic therapies to treat cancer.

“We see the fruits of the research,” Cowan says. “It’s led to a decrease in the incidence of cancer and an increase in survival of patients who develop cancer. We believe this is just the beginning.”
University of Nebraska
3835 Holdrege Street, Lincoln, Nebraska 68583 | 402.472.2111 | Comments?
©2017 University of Nebraska Board of Regents